Search the collection

5 results for Selmaj,+Krzysztof,+Prof

Sort by:

Sort by

Limit results to:

20 per page

5 results for Selmaj,+Krzysztof,+Prof

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
Author / Creator:Gold, Ralf, Prof ; Giovannoni, Gavin, Prof ; Selmaj, Krzysztof, Prof ; Havrdova, Eva, Prof ; Montalban, Xavier, Prof ; Radue, Ernst-Wilhelm, Prof ; Stefoski, Dusan, MD ; Robinson, Randy, PhD ; Riester, Katherine, MPH ; Rana, Jitesh, MD ; Elkins, Jacob, MD ; O'Neill, Gilmore, MRCPI
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
Author / Creator:Selmaj, Krzysztof, Prof ; Li, David KB, Prof ; Hartung, Hans-Peter, Prof ; Hemmer, Bernhard, Prof ; Kappos, Ludwig, Prof ; Freedman, Mark S, Prof ; Stüve, Olaf, MD ; Rieckmann, Peter, Prof ; Montalban, Xavier, Prof ; Ziemssen, Tjalf, MD ; Auberson, Lixin Zhang, MD ; Pohlmann, Harald, MSc ; Mercier, Francois, PhD ; Dahlke, Frank, MD ; Wallström, Erik, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2013-08, Vol.12 (8), p.756-767
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial
Author / Creator:Giovannoni, Gavin, Prof ; Gold, Ralf, Prof ; Selmaj, Krzysztof, Prof ; Havrdova, Eva, Prof ; Montalban, Xavier, Prof ; Radue, Ernst-Wilhelm, Prof ; Stefoski, Dusan, MD ; McNeill, Manjit, MSc ; Amaravadi, Lakshmi, PhD ; Sweetser, Marianne, MD ; Elkins, Jacob, MD ; O'Neill, Gilmore, MRCPI
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2014-05, Vol.13 (5), p.472-481
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Author / Creator:Coles, Alasdair J, Dr ; Twyman, Cary L, MD ; Arnold, Douglas L, Prof ; Cohen, Jeffrey A, Prof ; Confavreux, Christian, Prof ; Fox, Edward J, MD ; Hartung, Hans-Peter, Prof ; Havrdova, Eva, Prof ; Selmaj, Krzysztof W, Prof ; Weiner, Howard L, Prof ; Miller, Tamara, MD ; Fisher, Elizabeth, PhD ; Sandbrink, Rupert, MD ; Lake, Stephen L, ScD ; Margolin, David H, MD ; Oyuela, Pedro, MD ; Panzara, Michael A, MD ; Compston, D Alastair S, Prof
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2012-11, Vol.380 (9856), p.1829-1839
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Author / Creator:Cohen, Jeffrey A, Prof ; Coles, Alasdair J, PhD ; Arnold, Douglas L, Prof ; Confavreux, Christian, Prof ; Fox, Edward J, MD ; Hartung, Hans-Peter, Prof ; Havrdova, Eva, Prof ; Selmaj, Krzysztof W, Prof ; Weiner, Howard L, Prof ; Fisher, Elizabeth, PhD ; Brinar, Vesna V, MD ; Giovannoni, Gavin, Prof ; Stojanovic, Miroslav, MD ; Ertik, Bella I, MD ; Lake, Stephen L, ScD ; Margolin, David H, MD ; Panzara, Michael A, MD ; Compston, D Alastair S, Prof
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2012-11, Vol.380 (9856), p.1819-1828
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Search the collection

Export record to excel

Export this record

Export record to excel

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Export this record

Export record to excel

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Export this record

Export record to excel

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Export this record

Export record to excel

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Export this record

Export record to excel

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Refine your search